Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:1297-1304
Published online before print April 5, 2007, doi: 10.1161/ATVBAHA.106.138701
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
27/6/1297    most recent
ATVBAHA.106.138701v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ichihara, S.
Right arrow Articles by Murohara, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ichihara, S.
Right arrow Articles by Murohara, T.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*BENZO(A)PYRENE
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:1297.)
© 2007 American Heart Association, Inc.


Vascular Biology

A Role for the Aryl Hydrocarbon Receptor in Regulation of Ischemia-Induced Angiogenesis

Sahoko Ichihara; Yoshiji Yamada; Gaku Ichihara; Tamie Nakajima; Ping Li; Takahisa Kondo; Frank J. Gonzalez; Toyoaki Murohara

From the Department of Human Functional Genomics (S.I., Y.Y.), Life Science Research Center, Mie University, Tsu, Japan; Social Life Science (S.I., G.I., T.N.) and Department of Cardiology (P.L., T.K., T.M.), Nagoya University Graduate School of Medicine, Nagoya, Japan; and the Laboratory of Metabolism (F.J.G.), National Cancer Institute, NIH, Bethesda, Md.

Correspondence to Sahoko Ichihara, MD, PhD, Department of Human Functional Genomics, Life Science Research Center, Mie University, 1577 Kurimamachiya-cho, Tsu 514-8507, Japan. E-mail saho{at}gene.mie-u.ac.jp

Objective— The aryl hydrocarbon receptor (AHR) is a transcription factor that binds to DNA as a heterodimer with the AHR nuclear translocator (ARNT) after interaction with ligands such as polycyclic and halogenated aromatic hydrocarbons found in tobacco smoke and the environment. We have investigated the interaction between AHR and hypoxia signaling pathways in regulation of angiogenesis with the use of a surgical model of ischemia.

Methods and Results— Ischemia was induced by femoral artery occlusion in wild-type and AHR-null mice. Ischemia-induced angiogenesis was markedly enhanced in AHR-null mice compared with that in wild-type animals. Ischemia-induced upregulation of the expression of hypoxia-inducible factor–1{alpha} (HIF-1{alpha}) and ARNT as well as that of target genes for these transcription factors, such as that for vascular endothelial growth factor (VEGF), were also enhanced in AHR-null mice. Furthermore, the DNA binding activity of the HIF-1{alpha}–ARNT complex as well as the association of HIF-1{alpha} and ARNT with the VEGF gene promoter were increased by ischemia to a greater extent in AHR-null mice than in wild-type animals.

Conclusions— Ablation of AHR resulted in enhancement of ischemia-induced angiogenesis. This effect was likely attributable in part to the associated enhancement of ischemia-induced VEGF expression, which in turn may be caused by an increased abundance and activity of the HIF-1{alpha}–ARNT heterodimer.

Ischemia-induced angiogenesis was markedly enhanced in aryl hydrocarbon receptor (AHR)-null mice. This effect may be attributable to an increased association of hypoxia-inducible factor-1{alpha} with the AHR nuclear translocator and a consequent increased production of vascular endothelial growth factor in AHR-null mice.


Key Words: angiogenesis • hypoxia • ischemia • peripheral vascular disease • smoking




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. C. Roman, J. M. Carvajal-Gonzalez, E. M. Rico-Leo, and P. M. Fernandez-Salguero
Dioxin Receptor Deficiency Impairs Angiogenesis by a Mechanism Involving VEGF-A Depletion in the Endothelium and Transforming Growth Factor-{beta} Overexpression in the Stroma
J. Biol. Chem., September 11, 2009; 284(37): 25135 - 25148.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
A. Takeuchi, M. Takeuchi, K. Oikawa, K.-h. Sonoda, Y. Usui, Y. Okunuki, A. Takeda, Y. Oshima, K. Yoshida, M. Usui, et al.
Effects of Dioxin on Vascular Endothelial Growth Factor (VEGF) Production in the Retina Associated with Choroidal Neovascularization
Invest. Ophthalmol. Vis. Sci., July 1, 2009; 50(7): 3410 - 3416.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. Dabir, T. E. Marinic, I. Krukovets, and O. I. Stenina
Aryl Hydrocarbon Receptor Is Activated by Glucose and Regulates the Thrombospondin-1 Gene Promoter in Endothelial Cells
Circ. Res., June 20, 2008; 102(12): 1558 - 1565.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. K. Lund, L. N. Agbor, N. Zhang, A. Baker, H. Zhao, G. D. Fink, N. L. Kanagy, and M. K. Walker
Loss of the Aryl Hydrocarbon Receptor Induces Hypoxemia, Endothelin-1, and Systemic Hypertension at Modest Altitude
Hypertension, March 1, 2008; 51(3): 803 - 809.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
S. Banu, S. Ichihara, F. Huang, H. Ito, Y. Inaguma, K. Furuhashi, Y. Fukunaga, Q. Wang, J. Kitoh, H. Ando, et al.
Reversibility of the Adverse Effects of 1-Bromopropane Exposure in Rats
Toxicol. Sci., December 1, 2007; 100(2): 504 - 512.
[Abstract] [Full Text] [PDF]